Junjun Liu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Fibroblast Activation Protein Promotes Thoracic Aortic Dissection via PLAUR/ITGB1-Mediated Pro-inflammatory Macrophage Polarization.

Fibroblast Activation Protein Promotes Thoracic Aortic Dissection via PLAUR/ITGB1-Mediated Pro-inflammatory Macrophage Polarization.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 05, 2025

Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering.

Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 05, 2025

A novel ROR1-targeting antibody-PROTAC conjugate promotes BRD4 degradation for solid tumor treatment.

A novel ROR1-targeting antibody-PROTAC conjugate promotes BRD4 degradation for solid tumor treatment.

Journal: Theranostics

Published: August 19, 2024

Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors.

Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors.

Journal: International immunopharmacology

Published: May 27, 2024

The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer.

The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 26, 2024

Characterization of a novel T cell-engaging bispecific antibody for elimination of L1CAM-positive tumors.

Characterization of a novel T cell-engaging bispecific antibody for elimination of L1CAM-positive tumors.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 31, 2023

Binding domain on CD22 molecules contributing to the biological activity of T cell-engaging bispecific antibodies.

Binding domain on CD22 molecules contributing to the biological activity of T cell-engaging bispecific antibodies.

Journal: Heliyon

Published: December 31, 2022

Dual Function of CCAT2 in Regulating Luminal Subtype of Breast Cancer Depending on the Subcellular Distribution.

Dual Function of CCAT2 in Regulating Luminal Subtype of Breast Cancer Depending on the Subcellular Distribution.

Journal: Cancers

Published: December 28, 2022

Detection of breast cancer cells by a near-infrared fluorescent probe targeting mitochondrial viscosity.

Detection of breast cancer cells by a near-infrared fluorescent probe targeting mitochondrial viscosity.

Journal: Heliyon

Published: October 12, 2022

Anthelminthic niclosamide inhibits tumor growth and invasion in cisplatin-resistant human epidermal growth factor receptor 2-positive breast cancer.

Anthelminthic niclosamide inhibits tumor growth and invasion in cisplatin-resistant human epidermal growth factor receptor 2-positive breast cancer.

Journal: Oncology letters

Published: December 26, 2020

Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells.

Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells.

Journal: Pharmacological research

Published: October 10, 2019

Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells.

Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells.

Journal: Frontiers in genetics

Published: February 22, 2019

Showing 1-12 of 30

Last Updated: 09/26/2026